Introduction
More than 600,000 people die from Hepatocellular Carcinoma (HCC) each year. Worldwide research on the disease needs to be intensified in both the medical and pharmaceutical fields, especially with a focus on providing help to areas where resources are limited.
Translated Versions
Review Team
- Peter Ferenci (Chair, Austria)
- Michael Fried (Switzerland)
- Douglas Labrecque (USA)
- Jordi. Bruix (Spain)
- Morris Sherman (Canada)
- Masao Omata (Japan)
- Jenny Heathcote (Canada)
- Teehra Piratsivuth (Thailand)
- Mike Kew (South Africa)
- Jesse A. Otegbayo (Nigeria)
- S.S. Zheng (China)
- Shiv Kumar Sarin (India)
- Saeed S. Hamid (Pakistan)
- Salma Barakat Modawi (Sudan)
- Wolfgang Fleig (Germany)
- Suliman Fedail (Sudan)
- Alan Thomson (Canada)
- Aamir Khan (Pakistan)
- Peter Malfertheiner (Germany)
- George Lau (Hong Kong)
- Flair J. Carillo (Brazil)
- Justus H. Krabshuis (France)
- Anton Le Mair (The Netherlands)
English
French
Mandarin
Russian
Spanish